Antimycobacterial activities of 2,4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductase
about
Identification and characterization of a unique adenosine kinase from Mycobacterium tuberculosisCoMFA and CoMSIA 3D-QSAR analysis of DMDP derivatives as anti-cancer agentsNew Mycobacterium avium antifolate shows synergistic effect when used in combination with dihydropteroate synthase inhibitors.A screen to identify small molecule inhibitors of protein-protein interactions in mycobacteria.Synthesis and biological activity of substituted 2,4-diaminopyrimidines that inhibit Bacillus anthracis.Functional cloning of Bacillus anthracis dihydrofolate reductase and confirmation of natural resistance to trimethoprim.Dihydrofolate reductase as a therapeutic target for infectious diseases: opportunities and challenges.Identification of antimicrobial activity among new sulfonamide metal complexes for combating rapidly growing mycobacteria.Molecular docking studies on DMDP derivatives as human DHFR inhibitors.Synthesis, Antimicrobial and cytotoxic activity of New Heterocyclic Hybrids Based on 2,5-Dimethylpyrrole and Pyrrole Scaffolds.Synthesis and 3D-QSAR analysis of 2-chloroquinoline derivatives as H37 RV MTB inhibitors.Interactions of 5-deazapteridine derivatives with Mycobacterium tuberculosis and with human dihydrofolate reductases.Binding mode analysis of 2,4-diamino-5-methyl-5-deaza-6-substituted pteridines with Mycobacterium tuberculosis and human dihydrofolate reductases.Structure based drug discovery for designing leads for the non-toxic metabolic targets in multi drug resistant Mycobacterium tuberculosis.The search for new DHFR inhibitors: a review of patents, January 2001 – February 2005Synthesis and Antibacterial, Antimycobacterial Activity of 7-[4-{5-(2-Oxo-2-p-substituted-phenylethylthio)-1,3,4-thiadiazol-2yl}-3′-methylpiperazinyl] Quinolone Derivatives
P2860
Q28486351-CA1213B7-FF93-42C9-916B-6D80DA6893A6Q30483442-58C019ED-2FEC-4D90-B258-3F3A3782FB06Q34123691-72E62353-589C-481E-A740-4B951C68A537Q35007917-5810D7D4-0113-4318-8AD0-BF3A0F30A145Q36129198-382D0735-F819-4675-823D-DEC3BD17CA43Q37624548-6F35991D-5375-4F48-98A0-37CD8DF8C492Q38026606-FF49F863-6C98-48F5-84A2-8905B996340DQ40560940-D5A1C642-E595-443B-B5FC-46D199BF080CQ42092699-67D1857E-6DF1-46CB-BEDE-4869D84DF2ECQ42131893-5A138C92-C0FF-4514-A7FE-28B417874E2EQ42710585-768E9E65-3916-4FD6-ADD4-7B9831155DD1Q45022698-321BAA5C-18B4-4BDF-8429-5732CAEF520FQ46841766-0AC1590E-5D5D-4EC5-A313-32A5F30CE3EEQ47141887-AF525549-1B4D-4283-BE48-C1E0D3654E48Q57964414-525AC73B-22D2-460F-8908-AFDCB936D22DQ59008835-3E62A319-20FA-4B79-B42F-6946459F664A
P2860
Antimycobacterial activities of 2,4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductase
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Antimycobacterial activities o ...... terial dihydrofolate reductase
@ast
Antimycobacterial activities o ...... terial dihydrofolate reductase
@en
Antimycobacterial activities o ...... terial dihydrofolate reductase
@nl
type
label
Antimycobacterial activities o ...... terial dihydrofolate reductase
@ast
Antimycobacterial activities o ...... terial dihydrofolate reductase
@en
Antimycobacterial activities o ...... terial dihydrofolate reductase
@nl
prefLabel
Antimycobacterial activities o ...... terial dihydrofolate reductase
@ast
Antimycobacterial activities o ...... terial dihydrofolate reductase
@en
Antimycobacterial activities o ...... terial dihydrofolate reductase
@nl
P2093
P2860
P1476
Antimycobacterial activities o ...... terial dihydrofolate reductase
@en
P2093
E W Barrow
L Westbrook
R C Reynolds
S Zywno-Van-Ginkel
W J Suling
W W Barrow
P2860
P304
P356
10.1128/AAC.44.10.2784-2793.2000
P407
P577
2000-10-01T00:00:00Z